Guangzhou Wanfu Biotechnology Co., Ltd., Xiu'er, founded in 1992, is a well-known brand of pregnancy test sticks/early pregnancy test strips under Wanfu, and is a high-tech enterprise dedicated to the research and development, production and sales of rapid testing products (including reagents and instruments) in the biomedical in vitro diagnostic industry
Founded in 1992 with a registered capital of 88 million yuan, Guangzhou Wanfu Biotechnology Co., Ltd. is committed to the research and development, production and sales of point-of-care testing (POCT) products (including reagents and instruments) in the biomedical in vitro diagnosis (IVD) industry. After 20 years of unremitting efforts, Wanfu is gradually standing out in the medical diagnosis and rapid testing industry, walking in the forefront of the POCT industry, and Wanfu people are making unremitting efforts to become the "leader of China's POCT industry".
Wanfu is the first in vitro diagnostic reagent company in China to pass the on-site assessment of the US Food and Drug Administration (FDA) with "zero defect", and has been successively recognized as "National High-tech Enterprise", "National Development and Reform Commission Bioengineering High-tech Industrialization Demonstration Base", and "Key Enterprises for the Export of Electromechanical and High-tech Products" by the Ministry of Commerce. The company has passed the international authoritative quality management system certification of CE, ISO9001 and ISO13485 in Europe, and is one of the first enterprises in the country to pass the "Implementation Rules for the Production of In Vitro Diagnostic Reagents", and has established an internationally advanced colloidal gold rapid diagnostic reagent production line, with a clean production workshop of 2,000 square meters, and an annual production capacity of 160 million copies.
The company has more than 5,000 square meters of R&D laboratory, the introduction of the National Institutes of Health (NIH) and FDA senior scientists leading scientific and technological research and development team, the existing staff of nearly 1,200 people, the proportion of research and development personnel more than 20%, 12 doctors, 122 masters, in 2011 the National Development and Reform Commission approved the establishment of "national and local joint self-test rapid diagnosis engineering laboratory" in our company, research and development products cover cardiovascular diseases, There are more than 100 kinds of products such as infection markers, diabetes, kidney disease, respiratory diseases, thyroid diseases, digestive tract diseases, tumors, autoimmunity, eugenics, infectious diseases, quality controls, biological raw materials, drug testing and instrument and reagent integration.
In 2012, the company implemented the integration of "production, education, research and application" and made gratifying progress. "Market-oriented, customer-centric" has been deeply rooted in the hearts of every Wanfu people. It is Wanfu's continuous pursuit to provide better products and services to every customer.
It is under the traction of the unchanged concept of "market-oriented, customer-centric" that Wanfu's sales volume has increased year by year, and has become one of the top medical device manufacturers in China and a leader in the POCT industry.
Achievements only represent the past, 20 years of trials and hardships, Wanfu people have been reminding themselves all the time to create a more brilliant tomorrow. Carry out "in-depth marketing" to understand the real needs of the market in the front line; Increase R&D investment and respond quickly according to market demand; Improve production methods and lay a solid foundation for faster and better output......
This is Wanfu, strong, ambitious, down-to-earth, perseverance!
